VRIZOLE-HQ CREAM is a triple combination of Hydroquinone, Tretinoin & Mometasone Furoate which is used in Melasma and other Hyperpigmentary disorders. The Pigmentary Disorders Academy (PDA) Consensus Recommends that “The First-line therapy for Melasma should consist of fixed triple combination Topical Therapies.”
– Hydroquinone in VRIZOLE-HQ CREAM Suppresses the melanocyte metabolic processes and offers Synergistic mechanism of action.
– Tretinoin in VRIZOLE-HQ CREAM Promotes decrease in melanosome transfer and also increases the potency of Hydroquinone.
– Mometasone Furoate in VRIZOLE-HQ CREAM Reduces the irritative effects of hypopigmenting agents and inhibits melanin synthesis by decreasing cellular metabolism.